Clinical trials

  • ranibizumab for Neovascular age-related macular degeneration (nAMD)
  • SACITUZUMAB TIRUMOTECAN for Triple-negative breast cancer (locally recurrent unresectable or metastatic)
  • BI 3031185 for Healthy volunteer
  • AUTOLOGOUS T-CELLS TRANSDUCED WITH LENTIVIRAL VECTOR EXPRESSING A CHIMERIC ANTIGEN RECEPTOR DIRECTED AGAINST CD19 for Systemic sclerosis|Idiopathic inflammatory myopathy|Systemic lupus erythematosus
  • Etanercept for SAPHO syndrome
  • SKB410 for Advanced/metastatic solid tumor
  • TEMOZOLOMIDE for Diffuse low-grade glioma
  • ITEPEKIMAB for Chronic rhinosinusitis with nasal polyps
  • Methylphenidate hydrochloride for Attention deficit hyperactivity disorder (ADHD)
  • ITEPEKIMAB for Chronic rhinosinusitis with nasal polyps
  • GEMCITABINE for Perihilar cholangiocarcinoma | Distal cholangiocarcinoma
  • 1-[2-[4-(2,4-DIFLUOROPHENOXY)PIPERIDIN-1-YL]-3-[[(3R)-OXOLAN-3-YL]AMINO]-7,8-DIHYDRO-5H-PYRIDO[3,4-B]PYRAZIN-6-YL]ETHANONE for Parkinson's disease